Swarm was formed in 2022 and has now emerged with Martin Olin – previously chief executive of BerGenBio and Symphogen – at ...
The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...
On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback